Title

DNA-protein kinase catalytic subunit-interacting protein KIP binds telomerase by interacting with human telomerase reverse transcriptase

Authors

Authors

G. E. Lee; E. Y. Yu; C. H. Cho; J. Lee; M. T. Muller;I. K. Chung

Comments

Authors: contact us about adding a copy of your work at STARS@ucf.edu

Abbreviated Journal Title

J. Biol. Chem.

Keywords

G-STRAND OVERHANG; MAMMALIAN TELOMERASE; LENGTH MAINTENANCE; IMMORTAL; CELLS; CANCER; PKCS; GENE; IDENTIFICATION; REPLICATION; REPEATS; Biochemistry & Molecular Biology

Abstract

Telomere homeostasis, a process that is essential for continued cell proliferation and genomic stability, is regulated by endogenous telomerase and a collection of associated proteins. In this paper, a protein called KIP ( previously reported as a protein that binds specifically to DNA-dependent protein kinase), has been identified as a telomerase-regulating activity based on the following pieces of evidence. First, complexes between KIP and the catalytic subunit of telomerase ( hTERT) were identified using the yeast two-hybrid technique. Second, antibodies specific to KIP immunoprecipitate human telomerase in cell-free extracts. Third, immunolocalization experiments demonstrate that KIP is a nuclear protein that co-localizes with hTERT in cells. Fourth, KIP binds to hTERT both in vitro and in vivo in the absence of human telomerase RNA or telomeric DNA, thus defining the catalytic subunit of telomerase as the site of physical interaction. Fifth, co-immunoprecipitation experiments suggest that KIP-hTERT complexes form readily in cells and that overexpression of KIP in telomerase-positive cells increases endogenous telomerase activity. Finally, continued overexpression of KIP ( 60 population doublings) resulted in cells with elongated telomeres; thus, KIP directly or indirectly stimulates telomerase activity through hTERT and contributes to telomere lengthening. The collective data in this paper suggest that KIP plays a positive role in telomere length maintenance and/or regulation and may represent a novel target for anti-cancer drug development.

Journal Title

Journal of Biological Chemistry

Volume

279

Issue/Number

33

Publication Date

1-1-2004

Document Type

Article

Language

English

First Page

34750

Last Page

34755

WOS Identifier

WOS:000223134800081

ISSN

0021-9258

Share

COinS